PT Indofarma Tbk
IDX:INAF.JK
126 (IDR) • At close July 23, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | PT Indofarma Tbk |
Symbool | INAF.JK |
Munteenheid | IDR |
Prijs | 126 |
Beurswaarde | 390,508,020,000 |
Dividendpercentage | 0% |
52-weken bereik | 126 - 725 |
Industrie | Drug Manufacturers—Specialty & Generic |
Sector | Healthcare |
CEO | Mr. Jejen Nugraha |
Website | https://indofarma.id |
An error occurred while fetching data.
Over PT Indofarma Tbk
PT Indofarma Tbk, together with its subsidiaries, manufactures and markets pharmaceutical products in Indonesia. The company trades in and distributes drugs, medical devices, medical supplies, extracts, and herbals; and operates laboratory. It also provides COVID-19 test services, including rapid diagnostic test antigen; reverse transcription polymerase chain reaction, and genose. The
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (IDR)
Cijfers zijn in miljoenen (IDR)